People who chose to get the Pfizer vaccine to protect themselves from severe coronavirus symptoms will “likely” need a third booster dose within 12 months after full vaccination.
This was announced this Thursday by Albert Bourla, CEO of Pfizer, during an interview with CNBC.
Pharmaceuticals Pfizer-BioNTech reported in February that they were testing a third dose of their COVID-19 vaccine to better understand the immune response against new variants of the virus.
The White House coronavirus team said this week that Americans should prepare to receive booster injections to protect against variants of the coronavirus.
Pfizer’s vaccine was the first to receive emergency use approval in the United States from the Food and Drug Administration (FDA).
Pharmaceutical companies Pfizer and BioNTech recently reported that their COVID-19 vaccine remains highly effective. for at least six months after given the second dose and also works against the South African variant of the virus.
According to the companies, the vaccine has shown 91.3% effectiveness against COVID-19 up to six months after the second dose was administered and 100% effective in preventing severe cases, as defined by the Centers for Control and Disease Prevention (CDC).
– .
